‘Profitability On The Horizon’ For UV-C Disinfection Solution Company Germitec

Germitec Raised $30M Series B Financing Round For Sustained Two-Year Growth

 
• By Natasha Barrow

France-based Germitec aims to double its yearly revenue by expanding its UV-C disinfection technology for endocavitary ultrasound probes into the US market.

Germitec's technology delivers germicidal UV-C radiation to kill viruses and bacteria.
Germitec's technology delivers germicidal UV-C radiation to kill viruses and bacteria. (Shutterstock)

More from Financing

More from Market Intelligence